Young laboratory woman with testtubes

Recent News

March 2019

aTen Therapeutics attends Crown Bioscience’s Oncology Drug Discovery Symposium in Cambridge, exploring future approaches to cancer therapies.

February 2019

aTen Therapeutics welcomes Deanna Olubadewo as our new Research Assistant, on a work placement from the University of Edinburgh, via the Santander Universities Scheme.

aTen Therapeutics

An innovative biotechnology company.

We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.

Tensinomab product logo

Our novel antibody with huge therapeutic potential.

© aTen Therapeutics 2019. All rights reserved